Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack )

Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack ) About

Paxobrook tablets, a generic version of the brand-name drug Paxlovid, are used to treat mild-to-moderate coronavirus disease (COVID-19) in people who are at high risk of developing severe symptoms that could lead to hospitalization or death

How Does Paxobrook Tab Work?

Paxobrook Tab contains Nirmatrelvir and Ritonavir, a combination of protease inhibitors. These tablets block a key enzyme needed for SARS-CoV-2, the virus causing COVID-19, to replicate in the body. By preventing viral multiplication, Paxobrook Tab helps reduce the severity and progression of COVID-19 in high-risk adults when taken as directed by a physician.


Who Should Use Paxobrook Tab?

This medication is recommended for adults diagnosed with mild to moderate COVID-19 who are at increased risk of progressing to severe disease. Paxobrook Tab is not recommended for pediatric patients, pregnant or breastfeeding women unless specifically directed by a healthcare provider. Patients must have no known hypersensitivity to either Nirmatrelvir, Ritonavir, or any related excipients.


How Should Paxobrook Tab Be Taken?

Paxobrook Tab should be taken orally, strictly following the dosage and schedule provided by your physician. The standard combipack contains six tablets (four Nirmatrelvir, two Ritonavir). Swallow the tablets whole with water and avoid exceeding the prescribed amount. It is important to complete the entire course for optimal antiviral benefits.